METTL3
In a mouse study of age-related hearing loss, METTL3 reduces cochlear damage and hearing loss; it also reduces inflammation in LPS- and D-galactose-treated mouse cells. Cell and mouse changes each come from a single group, although five findings span two independent labs. The National Natural Science Foundation of China funds most of this work.
- 2 independent labs in 1 country
- Funders: National Natural Science Foundation of China and 2 more
- Animals4
Interventions
1Estradiol
upin mouse cells1
1 study
Estradiol
upin mouse cells1
Estradiol increases METTL3 in mouse cells.
Cellsin BMSCs
Pathology, research and practice4 Sep 2026
Effects
4Inflammation
downin mouse cells1
1 study
Inflammation
downin mouse cells1
METTL3 decreases inflammation in mouse cells.
Cellsin HEI-OC1 cells treated with LPS and D-galactose
Journal of molecular medicine (Berlin, Germany)18 Sep 2026
NF-κB signalling
downin mice1
1 study
NF-κB signalling
downin mice1
METTL3 inhibits NF-κB signalling in mice.
Animalsin ARHL micecochlea
Journal of molecular medicine (Berlin, Germany)18 Sep 2026
Cochlear damage
downin mice1
1 study
Cochlear damage
downin mice1
METTL3 decreases cochlear damage in mice.
Animalsin ARHL micecochlea
Journal of molecular medicine (Berlin, Germany)18 Sep 2026
Hearing loss
downin mice1
1 study
Hearing loss
downin mice1
METTL3 decreases hearing loss in mice.
Animalsin ARHL micecochlea
Journal of molecular medicine (Berlin, Germany)18 Sep 2026
Funding
3 grants since 2023National Heart, Lung, and Blood InstituteUS$1.3mNational Institute on AgingUS$525.6k
METTL3 in Cardiac Benefits of Exercise in Diabetes
National Heart, Lung, and Blood InstituteMassachusetts General HospitalUS$593.8k2024–2029
METTL3 in Heart Failure With Preserved Ejection Fraction
National Heart, Lung, and Blood InstituteMassachusetts General HospitalUS$747.3k2026–2030
METTL3 in regulation of the aging process
National Institute on AgingBrown UniversityUS$525.6k2023–2028